KeyBioscience SA is a biotechnology company focused on the discovery and development of fully human monoclonal antibodies for the prevention and treatment of serious bacterial and viral infections in the hospital setting. It applies the MabIgX® technology to generate and select fully human monoclonal antibodies and is developing candidates such as KBRV201 targeting respiratory syncytial virus (RSV).
AI-generated
Comparisons
KeyBioscience SA in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank KeyBioscience SA by reviews, experience and specialisations.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.